Consultant HaematologistAlfred Hospital and Monash UniversityMelbourne, Victoria, Australia
N/A
(1553093) Time-limited venetoclax-rituximab is effective for patients with Bruton tyrosine kinase exposed chronic lymphocytic leukaemia, but durable treatment-free remissions are uncommon
Friday, October 6, 20231:30 PM – 1:40 PM EDT
(1548587) Genomic Evolution and Resistance to Pirtobrutinib in Covalent BTK-Inhibitor Pre-treated Chronic Lymphocytic Leukemia Patients: Results from the Phase I/II BRUIN Study
Sunday, October 8, 202312:35 PM – 12:40 PM EDT